Effect of Chelation with Calcium Disodium EDTA on Haemato-biochemical and Trace Mineral Profile in Blood from Lead Exposed Calves
نویسنده
چکیده
An experiment was performed using 20 calves of about one-month old to investigate the effect of chelation therapy with calcium disodium ethylenediaminetetraacetate (CaNa2EDTA) alone or along with antioxidant α-tocopherol in lead loaded calves on blood trace minerals, erythrocytic sulfahydryl groups and some haematobiochemical parameters. Fifteen calves were given lead orally at a daily dose of 7.5 mg of 99% pure lead acetate/kg body weight for 28 days. Then the lead was withdrawn on day 28 and the calves were randomly divided into three groups. Each group of five animals was either treated with CaNa2EDTA alone at the dose rate of 110 mg/kg body weight in two divided doses for 4 days or along with α-tocopherol at the dose rate of 100 mg/kg body weight orally daily for 7 days, keeping the remaining five calves as lead-exposed untreated controls. Blood samples were collected at the end of the lead exposure (day 0) and thereafter on day 2, 4, 7 and 10 from the start of the chelation treatment. The treatment with EDTA alone led to slow but non-significant improvement in blood copper level, but incorporation of antioxidant α-tocopherol in chelation therapy resulted in its significant decline, as recorded on day 7-post treatment. Withdrawal of lead or treatment with CaNa2EDTA alone or along with αtocopherol enhanced the erythrocytic thiol contents and the levels of T-SH and P-SH became statistically (p<0.05) comparable to those of lead-exposed controls by day 7 and 4, respectively. There was no significant (p>0.05) change in serum urea, creatinine, total protein and albumin levels between the treatment groups. It is concluded from the present investigation that treatment with CaNa2EDTA at the present dose rate is safe to be used for chelation in lead loaded calves. (Asian-Aust. J. Anim. Sci. 2005. Vol 18, No. 8 : 1130-1134)
منابع مشابه
Effect of Disodium EDTA Chelation Regimen
TREATMENT OF LEAD TOXICITY with chelation was first reported with EDTA in the early 1950s. Apparent success in reducing metastatic calcium deposits led Clarke et al in 1956 to treat angina patients with EDTA, and others to use chelation for various forms of atherosclerotic disease. Chelation therapy evolved to constitute infusions of vitamins and disodium EDTA, a drug that binds divalent and so...
متن کاملEDTA chelation therapy in the treatment of toxic metals
BACKGROUND: Metal induced toxicity with wide range of physiological, biochemical and behavioral dysfunctions was reported in many studies. The chelation has been used for treatment to toxic metals’ exposure for many years. In our current clinical study, we compared different chelation protocols and two forms of EDTA (sodium calcium edetate and sodium edetate) in treatments of toxic metal exposu...
متن کاملGrowth Performance, Hematological and Mineral Profile of Post-Weaning Calves as Influenced by Inclusion of Pelleted-Concentrate Supplement Containing Essential Oils and Probiotics
Two experimental factors (dietary treatment with or without pelleted-concentrate supplement (PCS) and sex) were investigated in crossbreed post-weaning calves to monitor their effects on performance, hematological profile, and plasma mineral concentration. Twenty-four post-weaning calves were classified according to sexually (either male or female) and randomly distributed into two dietary trea...
متن کاملChelation Therapy: Unproven Claims and Unsound Theories
Chelation therapy, as discussed in this article, is a series of intravenous infusions containing disodium EDTA and various other substances. It is sometimes done by swallowing EDTA or other agents in pill form. Proponents claim that EDTA chelation therapy is effective against atherosclerosis and many other serious health problems. Its use is widespread because patients have been led to believe ...
متن کاملDoes calcium disodium EDTA slow CKD progression?
G iven the increasing incidence and prevalence of chronic kidney disease (CKD), approaches to slow disease progression are essential. For more than a decade, Ja-Liang Lin and colleagues have published randomized placebo-controlled clinical trials reporting that treatment with calcium disodium EDTA slows CKD progression. Lead chelation has been implicated as the mechanism, and benefits in diabet...
متن کامل